Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$IART Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.59 up 9.26% YoY • Reported revenue of $411.18M up 2.27% YoY • Integra LifeSciences expects Q4 2026 revenue of $413M to $433M and adjusted diluted EPS of $0.61 to $0.71; FY2026 revenue of $1.63B to $1.65B and adjusted EPS of $2.30 to $2.40.

Price since post

Full Details

Advertisement|Remove ads.